Breaking News Instant updates and real-time market news.

MSBI

Midland States

$17.52 /

+0.27 (+1.57%)

06:49
04/09/20
04/09
06:49
04/09/20
06:49

Stephens cuts Midland States to Equal Weight, prefers 'wait-and-see approach'

As previously reported, Stephens analyst Terry McEvoy downgraded Midland States to Equal Weight from Overweight with a price target of $20, down from $25. He prefers "a more wait-and-see approach" to how Midland's portfolio performs over the coming quarter, particularly its equipment finance and indirect consumer loans, McEvoy tells investors. The current situation also presents a risk to commercial FHA revenue and McEvoy sees a chance that management cuts the full-year revenue outlook, the analyst said.

  • 04

    May

MSBI Midland States
$17.52 /

+0.27 (+1.57%)

04/09/20 Stephens
Midland States downgraded to Equal Weight from Overweight at Stephens
04/01/20 Keefe Bruyette
Midland States downgraded to Market Perform from Outperform at Keefe Bruyette

TODAY'S FREE FLY STORIES

Recommendations
Dollar Tree price target raised to $97 from $87 at Deutsche Bank » 07:42
05/26/20
05/26
07:42
05/26/20
07:42
DLTR

Dollar Tree

$81.84 /

+0.63 (+0.78%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$81.84 /

+0.63 (+0.78%)

DLTR Dollar Tree
$81.84 /

+0.63 (+0.78%)

05/18/20 Gordon Haskett
Colgate, Dollar Tree speculated as possible Peltz targets by Gordon Haskett
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar Tree initiated with a Buy at Goldman Sachs
04/01/20 Citi
Dollar Tree upgraded to Buy from Neutral at Citi
DLTR Dollar Tree
$81.84 /

+0.63 (+0.78%)

DLTR Dollar Tree
$81.84 /

+0.63 (+0.78%)

DLTR Dollar Tree
$81.84 /

+0.63 (+0.78%)

DLTR Dollar Tree
$81.84 /

+0.63 (+0.78%)

Recommendations
Five Below price target raised to $102 from $99 at Deutsche Bank » 07:41
05/26/20
05/26
07:41
05/26/20
07:41
FIVE

Five Below

$99.70 /

+2.4 (+2.47%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FIVE Five Below
$99.70 /

+2.4 (+2.47%)

FIVE Five Below
$99.70 /

+2.4 (+2.47%)

05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Five Below initiated with a Neutral at Goldman Sachs
05/01/20 Loop Capital
Five Below price target raised to $110 from $80 at Loop Capital
04/30/20 JPMorgan
Five Below price target raised to $100 from $76 at JPMorgan
FIVE Five Below
$99.70 /

+2.4 (+2.47%)

FIVE Five Below
$99.70 /

+2.4 (+2.47%)

FIVE Five Below
$99.70 /

+2.4 (+2.47%)

Recommendations
Dollar General price target raised to $187 from $159 at Deutsche Bank » 07:41
05/26/20
05/26
07:41
05/26/20
07:41
DG

Dollar General

$179.00 /

+0.54 (+0.30%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DG Dollar General
$179.00 /

+0.54 (+0.30%)

DG Dollar General
$179.00 /

+0.54 (+0.30%)

05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar General initiated with a Buy at Goldman Sachs
04/30/20
Fly Intel: Top five analyst downgrades
04/30/20
Dollar General cut to Hold at Loop Capital on valuation
DG Dollar General
$179.00 /

+0.54 (+0.30%)

DG Dollar General
$179.00 /

+0.54 (+0.30%)

DG Dollar General
$179.00 /

+0.54 (+0.30%)

DG Dollar General
$179.00 /

+0.54 (+0.30%)

Recommendations
Big Lots price target raised to $31 from $19 at Deutsche Bank » 07:41
05/26/20
05/26
07:41
05/26/20
07:41
BIG

Big Lots

$32.40 /

-0.28 (-0.86%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIG Big Lots
$32.40 /

-0.28 (-0.86%)

BIG Big Lots
$32.40 /

-0.28 (-0.86%)

05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Big Lots initiated with a Neutral at Goldman Sachs
05/04/20
Fly Intel: Top five analyst upgrades
05/04/20 Telsey Advisory
Big Lots upgraded to Outperform from Market Perform at Telsey Advisory
BIG Big Lots
$32.40 /

-0.28 (-0.86%)

BIG Big Lots
$32.40 /

-0.28 (-0.86%)

BIG Big Lots
$32.40 /

-0.28 (-0.86%)

Conference/Events
New York Community Bancorp management to meet virtually with Piper Sandler » 07:40
05/26/20
05/26
07:40
05/26/20
07:40
NYCB

New York Community Bancorp

$9.07 /

-0.325 (-3.46%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NYCB New York Community Bancorp
$9.07 /

-0.325 (-3.46%)

NYCB New York Community Bancorp
$9.07 /

-0.325 (-3.46%)

04/14/20 Compass Point
New York Community Bancorp initiated with a Neutral at Compass Point
04/13/20 B. Riley FBR
New York Community Bancorp upgraded to Buy from Neutral at B. Riley FBR
04/13/20 RBC Capital
New York Community Bancorp upgraded to Outperform at RBC Capital
04/01/20 Keefe Bruyette
New York Community Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
NYCB New York Community Bancorp
$9.07 /

-0.325 (-3.46%)

Conference/Events
Newmark management to meet virtually with Piper Sandler » 07:40
05/26/20
05/26
07:40
05/26/20
07:40
NMRK

Newmark

$3.74 /

-0.17 (-4.35%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NMRK Newmark
$3.74 /

-0.17 (-4.35%)

NMRK Newmark
$3.74 /

-0.17 (-4.35%)

04/09/20 BofA
Newmark double-downgraded to Underperform from Buy at BofA
04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
02/14/20 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
NMRK Newmark
$3.74 /

-0.17 (-4.35%)

Syndicate
Warner Music launches IPO of 70M shares, sees pricing at $23-$26 per share » 07:40
05/26/20
05/26
07:40
05/26/20
07:40
WMG

Warner Music

$0.00 /

+ (+0.00%)

Warner Music Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
ContraFect announces stock purchase agreement with Pfizer » 07:39
05/26/20
05/26
07:39
05/26/20
07:39
CFRX

ContraFect

$5.47 /

+0.09 (+1.67%)

, PFE

Pfizer

$37.51 /

+0.25 (+0.67%)

ContraFect Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CFRX ContraFect
$5.47 /

+0.09 (+1.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

CFRX ContraFect
$5.47 /

+0.09 (+1.67%)

10/02/19 Piper Jaffray
Piper says design differentiates ContraFect trial from other antibiotic studies
06/11/19 Maxim
ContraFect initiated with a Buy at Maxim
PFE Pfizer
$37.51 /

+0.25 (+0.67%)

05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
05/15/20 Goldman Sachs
After Pfizer data, Goldman says Sarepta remains 'leader' in DMD gene therapy
05/15/20 JPMorgan
JPMorgan still sees Sarepta in pole position in DMD space
CFRX ContraFect
$5.47 /

+0.09 (+1.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

CFRX ContraFect
$5.47 /

+0.09 (+1.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

Recommendations
Inspire Medical price target raised to $95 from $81 at Wells Fargo » 07:39
05/26/20
05/26
07:39
05/26/20
07:39
INSP

Inspire Medical

$85.95 /

+4.5 (+5.52%)

Wells Fargo analyst Larry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INSP Inspire Medical
$85.95 /

+4.5 (+5.52%)

INSP Inspire Medical
$85.95 /

+4.5 (+5.52%)

05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Lake Street
Inspire Medical initiated with a Buy at Lake Street
05/06/20 Guggenheim
Inspire Medical price target raised to $90 from $80 at Guggenheim
04/28/20 BofA
Inspire Medical upgraded to Buy from Neutral at BofA
INSP Inspire Medical
$85.95 /

+4.5 (+5.52%)

INSP Inspire Medical
$85.95 /

+4.5 (+5.52%)

INSP Inspire Medical
$85.95 /

+4.5 (+5.52%)

Initiation
Synchronoss initiated with an Outperform at Northland » 07:38
05/26/20
05/26
07:38
05/26/20
07:38
SNCR

Synchronoss

$2.39 /

+0.01 (+0.42%)

Northland analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNCR Synchronoss
$2.39 /

+0.01 (+0.42%)

SNCR Synchronoss
$2.39 /

+0.01 (+0.42%)

05/11/20 Roth Capital
Synchronoss price target lowered to $9 from $13 at Roth Capital
12/20/19 Roth Capital
Roth says Synchronoss opportunity in advanced messaging looks underappreciated
09/09/19 Canaccord
Synchronoss weakness a buying opportunity, says Canaccord
08/27/19 Canaccord
Synchronoss initiated with a Buy at Canaccord
SNCR Synchronoss
$2.39 /

+0.01 (+0.42%)

Downgrade
Pinduoduo downgraded to Hold from Buy at China Renaissance » 07:38
05/26/20
05/26
07:38
05/26/20
07:38
PDD

Pinduoduo

$68.72 /

+8.68 (+14.46%)

China Renaissance analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

06:58 Today Benchmark
Pinduoduo price target raised to $76 from $38 at Benchmark
06:14 Today Nomura Instinet
Pinduoduo price target raised to $66 from $33.40 at Nomura Instinet
05/25/20 Jefferies
Pinduoduo downgraded to Hold from Buy at Jefferies
05/24/20 Goldman Sachs
Pinduoduo downgraded to Neutral from Buy at Goldman Sachs
PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

PDD Pinduoduo
$68.72 /

+8.68 (+14.46%)

Hot Stocks
Benefitfocus announces $80M investment by BuildGroup » 07:38
05/26/20
05/26
07:38
05/26/20
07:38
BNFT

Benefitfocus

$10.68 /

+0.14 (+1.33%)

Benefitfocus announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNFT Benefitfocus
$10.68 /

+0.14 (+1.33%)

BNFT Benefitfocus
$10.68 /

+0.14 (+1.33%)

05/07/20 Piper Sandler
Benefitfocus price target lowered to $26 from $35 at Piper Sandler
04/02/20 Cantor Fitzgerald
Benefitfocus shares attractive at current levels, says Cantor Fitzgerald
03/04/20 Wells Fargo
Benefitfocus price target lowered to $29 from $40 at Wells Fargo
03/04/20 Raymond James
Benefitfocus price target lowered to $16 from $25 at Raymond James
BNFT Benefitfocus
$10.68 /

+0.14 (+1.33%)

BNFT Benefitfocus
$10.68 /

+0.14 (+1.33%)

BNFT Benefitfocus
$10.68 /

+0.14 (+1.33%)

Initiation
Trillium Therapeutics initiated with an Outperform at JMP Securities » 07:38
05/26/20
05/26
07:38
05/26/20
07:38
TRIL

Trillium Therapeutics

$6.40 /

-0.35 (-5.19%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIL Trillium Therapeutics
$6.40 /

-0.35 (-5.19%)

TRIL Trillium Therapeutics
$6.40 /

-0.35 (-5.19%)

08/19/19
Fly Intel: Top five analyst downgrades
08/19/19 H.C. Wainwright
Trillium Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
TRIL Trillium Therapeutics
$6.40 /

-0.35 (-5.19%)

TRIL Trillium Therapeutics
$6.40 /

-0.35 (-5.19%)

TRIL Trillium Therapeutics
$6.40 /

-0.35 (-5.19%)

TRIL Trillium Therapeutics
$6.40 /

-0.35 (-5.19%)

Earnings
Comfort Systems USA resumes share repurchsaes, withdraws Q2 guidance » 07:37
05/26/20
05/26
07:37
05/26/20
07:37
FIX

Comfort Systems USA

$33.79 /

+0.05 (+0.15%)

Comfort Systems USA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FIX Comfort Systems USA
$33.79 /

+0.05 (+0.15%)

FIX Comfort Systems USA
$33.79 /

+0.05 (+0.15%)

04/29/20 DA Davidson
Comfort Systems USA downgraded to Neutral from Buy at DA Davidson
04/29/20 DA Davidson
Comfort Systems USA downgraded to Neutral from Buy at DA Davidson
04/20/20 Sidoti
Comfort Systems USA downgraded to Neutral from Buy at Sidoti
03/11/20 Sidoti
Comfort Systems USA upgraded to Buy from Neutral at Sidoti
FIX Comfort Systems USA
$33.79 /

+0.05 (+0.15%)

FIX Comfort Systems USA
$33.79 /

+0.05 (+0.15%)

Syndicate
ContraFect reports private placement of stock, warrants to Pfizer » 07:36
05/26/20
05/26
07:36
05/26/20
07:36
CFRX

ContraFect

$5.47 /

+0.09 (+1.67%)

, PFE

Pfizer

$37.51 /

+0.25 (+0.67%)

ContraFect Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFRX ContraFect
$5.47 /

+0.09 (+1.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

CFRX ContraFect
$5.47 /

+0.09 (+1.67%)

10/02/19 Piper Jaffray
Piper says design differentiates ContraFect trial from other antibiotic studies
06/11/19 Maxim
ContraFect initiated with a Buy at Maxim
PFE Pfizer
$37.51 /

+0.25 (+0.67%)

05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
05/15/20 Goldman Sachs
After Pfizer data, Goldman says Sarepta remains 'leader' in DMD gene therapy
05/15/20 JPMorgan
JPMorgan still sees Sarepta in pole position in DMD space
CFRX ContraFect
$5.47 /

+0.09 (+1.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

CFRX ContraFect
$5.47 /

+0.09 (+1.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

PFE Pfizer
$37.51 /

+0.25 (+0.67%)

Hot Stocks
Steelcase calls back most of manufacturing workforce » 07:36
05/26/20
05/26
07:36
05/26/20
07:36
SCS

Steelcase

$11.52 /

+0.395 (+3.55%)

Steelcase announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCS Steelcase
$11.52 /

+0.395 (+3.55%)

SCS Steelcase
$11.52 /

+0.395 (+3.55%)

05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
10/07/19 Raymond James
Raymond James steps away from three office furniture stocks
10/07/19 Raymond James
Steelcase downgraded to Market Perform from Strong Buy at Raymond James
09/23/19 Raymond James
Steelcase price target raised to $23 from $21 at Raymond James
SCS Steelcase
$11.52 /

+0.395 (+3.55%)

SCS Steelcase
$11.52 /

+0.395 (+3.55%)

SCS Steelcase
$11.52 /

+0.395 (+3.55%)

Recommendations
Carvana price target raised to $115 from $100 at Wells Fargo » 07:36
05/26/20
05/26
07:36
05/26/20
07:36
CVNA

Carvana

$96.63 /

+1.88 (+1.98%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$96.63 /

+1.88 (+1.98%)

CVNA Carvana
$96.63 /

+1.88 (+1.98%)

05/19/20 JPMorgan
Carvana price target raised to $75 from $65 at JPMorgan
05/13/20 Citi
Carvana price target raised to $120 from $95 at Citi
05/11/20 Oppenheimer
Carvana price target raised to $127 from $95 at Oppenheimer
05/07/20 Morgan Stanley
Morgan Stanley trims Carvana target to $23, stays Underweight after earnings
CVNA Carvana
$96.63 /

+1.88 (+1.98%)

CVNA Carvana
$96.63 /

+1.88 (+1.98%)

CVNA Carvana
$96.63 /

+1.88 (+1.98%)

CVNA Carvana
$96.63 /

+1.88 (+1.98%)

Earnings
Anaplan withdraws FY21 guidance due to COVID-19  07:35
05/26/20
05/26
07:35
05/26/20
07:35
PLAN

Anaplan

$51.07 /

+2.12 (+4.33%)

 
ShowHide Related Items >><<
PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
05/20/20 Mizuho
Mizuho boosts Anaplan target to $50, makes top pick into Software earnings
05/20/20 Wells Fargo
Wells Fargo downgrades Anaplan on 'more difficult near-term setup'
05/20/20 Wells Fargo
Anaplan downgraded to Equal Weight from Overweight at Wells Fargo
PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

Initiation
Chuy's resumed with an Overweight at Stephens » 07:35
05/26/20
05/26
07:35
05/26/20
07:35
CHUY

Chuy's

$16.30 /

+0.17 (+1.05%)

Stephens analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHUY Chuy's
$16.30 /

+0.17 (+1.05%)

CHUY Chuy's
$16.30 /

+0.17 (+1.05%)

04/23/20 BMO Capital
Chuy's upgraded to Market Perform from Underperform at BMO Capital
04/20/20 Raymond James
Chuy's price target raised to $17 from $14 at Raymond James
04/08/20 Wedbush
Chuy's price target lowered to $17 from $26 at Wedbush
04/02/20 Raymond James
Chuy's upgraded to Outperform from Market Perform at Raymond James
CHUY Chuy's
$16.30 /

+0.17 (+1.05%)

CHUY Chuy's
$16.30 /

+0.17 (+1.05%)

Hot Stocks
Anaplan sees Q2 revenue $103M-$104M, consensus $110.24M » 07:35
05/26/20
05/26
07:35
05/26/20
07:35
PLAN

Anaplan

$51.07 /

+2.12 (+4.33%)

Sees Q2 non-GAAP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
05/20/20 Mizuho
Mizuho boosts Anaplan target to $50, makes top pick into Software earnings
05/20/20 Wells Fargo
Wells Fargo downgrades Anaplan on 'more difficult near-term setup'
05/20/20 Wells Fargo
Anaplan downgraded to Equal Weight from Overweight at Wells Fargo
PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

Recommendations
Argenx price target raised to $258 from $198 at Piper Sandler » 07:35
05/26/20
05/26
07:35
05/26/20
07:35
ARGX

Argenx

$158.26 /

+2.26 (+1.45%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff raised the firm's price target on Argenx to $258 from $198 and reiterates an Overweight rating on the shares. The Phase III ADAPT trial of efgartigimod in generalized myasthenia gravis met the primary endpoint of Myasthenia Gravis Activities of Daily Living score response at 67.7% versus 29.7% on placebo, Tenthoff tells investors in a research note. The stock in morning trading is up 28%, or $44.54, to $202.50. Based on the top-line data, the analyst is confident in FDA approval and U.S. launch next year.

ShowHide Related Items >><<
ARGX Argenx
$158.26 /

+2.26 (+1.45%)

ARGX Argenx
$158.26 /

+2.26 (+1.45%)

07:08 Today Stifel
Argenx should trade up to 'mid-$180 range' after trial success, says Stifel
05/21/20 Credit Suisse
Argenx price target raised to $160 from $150 at Credit Suisse
05/14/20 JMP Securities
Argenx ADAPT Phase 3 trial in gMG remains on track, says JMP Securities
02/27/20 Piper Sandler
Argenx ended 2019 with cash of $1.34B, says Piper Sandler
ARGX Argenx
$158.26 /

+2.26 (+1.45%)

Options
Unusual call flow in option market yesterday » 07:35
05/26/20
05/26
07:35
05/26/20
07:35
JD

JD.com

$49.88 /

-2.7 (-5.14%)

, LB

L Brands

$15.08 /

+0.62 (+4.29%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JD JD.com
$49.88 /

-2.7 (-5.14%)

LB L Brands
$15.08 /

+0.62 (+4.29%)

JD JD.com
$49.88 /

-2.7 (-5.14%)

05/18/20 Benchmark
JD.com price target raised to $66 from $60 at Benchmark
05/18/20 Goldman Sachs
JD.com price target raised to $59 from $52 at Goldman Sachs
05/18/20 Stifel
JD.com price target raised to $50 from $43 at Stifel
05/18/20 Citi
JD.com price target raised to $60 from $56 at Citi
LB L Brands
$15.08 /

+0.62 (+4.29%)

05/22/20 Barclays
L Brands price target raised to $17 from $10 at Barclays
05/20/20 Jefferies
L Brands' risks at Bath & Body Works remain underappreciated, says Jefferies
05/05/20
Fly Intel: Top five analyst upgrades
05/05/20 B. Riley FBR
B. Riley FBR remains buyer of L Brands with $23 price target
JD JD.com
$49.88 /

-2.7 (-5.14%)

LB L Brands
$15.08 /

+0.62 (+4.29%)

JD JD.com
$49.88 /

-2.7 (-5.14%)

LB L Brands
$15.08 /

+0.62 (+4.29%)

JD JD.com
$49.88 /

-2.7 (-5.14%)

LB L Brands
$15.08 /

+0.62 (+4.29%)

JD JD.com
$49.88 /

-2.7 (-5.14%)

LB L Brands
$15.08 /

+0.62 (+4.29%)

Hot Stocks
Steelcase says March, April revenue decreased 39% versus last year » 07:34
05/26/20
05/26
07:34
05/26/20
07:34
SCS

Steelcase

$11.52 /

+0.395 (+3.55%)

Revenue for the fiscal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCS Steelcase
$11.52 /

+0.395 (+3.55%)

SCS Steelcase
$11.52 /

+0.395 (+3.55%)

05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
10/07/19 Raymond James
Raymond James steps away from three office furniture stocks
10/07/19 Raymond James
Steelcase downgraded to Market Perform from Strong Buy at Raymond James
09/23/19 Raymond James
Steelcase price target raised to $23 from $21 at Raymond James
SCS Steelcase
$11.52 /

+0.395 (+3.55%)

SCS Steelcase
$11.52 /

+0.395 (+3.55%)

SCS Steelcase
$11.52 /

+0.395 (+3.55%)

Earnings
Anaplan reports Q1 EPS (10c), consensus (14c) » 07:33
05/26/20
05/26
07:33
05/26/20
07:33
PLAN

Anaplan

$51.07 /

+2.12 (+4.33%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
05/20/20 Mizuho
Mizuho boosts Anaplan target to $50, makes top pick into Software earnings
05/20/20 Wells Fargo
Wells Fargo downgrades Anaplan on 'more difficult near-term setup'
05/20/20 Wells Fargo
Anaplan downgraded to Equal Weight from Overweight at Wells Fargo
PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

PLAN Anaplan
$51.07 /

+2.12 (+4.33%)

Initiation
Sorrento Therapeutics initiated with a Buy at Dawson James » 07:32
05/26/20
05/26
07:32
05/26/20
07:32
SRNE

Sorrento Therapeutics

$5.07 /

+0.04 (+0.80%)

Dawson James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$5.07 /

+0.04 (+0.80%)

SRNE Sorrento Therapeutics
$5.07 /

+0.04 (+0.80%)

10/07/19 JMP Securities
Sorrento Therapeutics initiated with an Outperform at JMP Securities
07/23/19 H.C. Wainwright
Sorrento Therapeutics price target lowered to $30 from $40 at H.C. Wainwright
SRNE Sorrento Therapeutics
$5.07 /

+0.04 (+0.80%)

SRNE Sorrento Therapeutics
$5.07 /

+0.04 (+0.80%)

SRNE Sorrento Therapeutics
$5.07 /

+0.04 (+0.80%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.